Axa Price To Sales Ratio from 2010 to 2024
| EQH Stock | USD 48.08 0.23 0.48% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 1.10736417 | Current Value 0.81 | Quarterly Volatility 0.15598776 |
Check Axa Equitable financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axa Equitable's main balance sheet or income statement drivers, such as Depreciation And Amortization of 545.7 M, Interest Expense of 174.7 M or Selling General Administrative of 2.4 B, as well as many indicators such as Price To Sales Ratio of 0.81, Dividend Yield of 0.022 or PTB Ratio of 4.62. Axa financial statements analysis is a perfect complement when working with Axa Equitable Valuation or Volatility modules.
Axa | Price To Sales Ratio |
Latest Axa Equitable's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of Axa Equitable Holdings over the last few years. Price to Sales Ratio is figured by comparing Axa Equitable Holdings stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Axa Equitable sales, a figure that is much harder to manipulate than other Axa Equitable Holdings multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Axa Equitable's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Axa Equitable's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 1.40 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
Axa Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 0.96 | |
| Geometric Mean | 0.95 | |
| Coefficient Of Variation | 16.30 | |
| Mean Deviation | 0.12 | |
| Median | 0.87 | |
| Standard Deviation | 0.16 | |
| Sample Variance | 0.02 | |
| Range | 0.5092 | |
| R-Value | 0.27 | |
| Mean Square Error | 0.02 | |
| R-Squared | 0.07 | |
| Significance | 0.34 | |
| Slope | 0.01 | |
| Total Sum of Squares | 0.34 |
Axa Price To Sales Ratio History
About Axa Equitable Financial Statements
Investors use fundamental indicators, such as Axa Equitable's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Axa Equitable's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 1.11 | 0.81 |
Currently Active Assets on Macroaxis
When determining whether Axa Equitable Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axa Equitable's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axa Equitable Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axa Equitable Holdings Stock:Check out the analysis of Axa Equitable Correlation against competitors. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Diversified Financial Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axa Equitable. If investors know Axa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axa Equitable listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.40) | Dividend Share 0.22 | Earnings Share (0.91) | Revenue Per Share 32.942 | Quarterly Revenue Growth (0.25) |
The market value of Axa Equitable Holdings is measured differently than its book value, which is the value of Axa that is recorded on the company's balance sheet. Investors also form their own opinion of Axa Equitable's value that differs from its market value or its book value, called intrinsic value, which is Axa Equitable's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axa Equitable's market value can be influenced by many factors that don't directly affect Axa Equitable's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axa Equitable's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axa Equitable is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axa Equitable's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.